There is also an ongoing cardiovascular outcomes trial of tirzepatide (SURPASS-CVOT) in individuals with type 2 diabetes and cardiovascular disease [91], which, if successful, will broaden the use of tirzepatide to those with manifest or increased risk for CVD, as is the case for GLP-1 receptor agonists [22]
Belief in UFOs, despite military pilot testimonies, does not constitute conclusive evidence of extraterrestrial life
Front Neurosci 7, 188 (2013)
Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial
That said, many studies dont always clearly state the percent concentration in userfriendly terms, or specify 1 % vs other concentrations